X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Eurosurveillance

期刊標題檢索 EUROSURVEILLANC 最新評論: This magazine has a high rejection rate. I have had two articles accep... (2023-07-16)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Eurosurveillance]您好,您是該頁面的第 23065 位訪客。

期刊簡介
期刊名稱Eurosurveillance Eurosurveillance
LetPub Score
8.3
50 ratings
Rate

Reputation
9.4

Influence
7.8

Speed
6.9

期刊簡稱EUROSURVEILLANCE
ISSN1560-7917
h-index90
CiteScore
CiteScoreSJRSNIPCiteScore Rank
32.702.8812.337
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Public Health, Environmental and Occupational Health
Q13 / 665
Category: Medicine
Subcategory: Infectious Diseases
Q16 / 344
Category: Medicine
Subcategory: Immunology and Microbiology (miscellaneous)
Q11 / 29
Category: Medicine
Subcategory: Virology
Q12 / 80
Category: Medicine
Subcategory: Microbiology
Q14 / 182
Category: Medicine
Subcategory: Microbiology (medical)
Q14 / 140
Category: Medicine
Subcategory: Epidemiology
Q15 / 148

自引率 (2023-2024)3.00%自引率趨勢
掲載範囲
Eurosurveillance aims to be the authoritative and representative public health voice of the communicable disease community in Europe and beyond. Our main focus is on Europe, and authors from other parts of the world are encouraged to submit articles, provided that they add value to a European audience.

Our main objectives are to:

provide facts and guidance for health professionals and decision-makers to facilitate the implementation of effective prevention and control measures;
support the preparedness and response to health threats in Europe through the rapid dissemination of high-quality authoritative scientific information on relevant outbreaks or emergency situations;
provide a European-specific platform for health professionals to share scientific findings in infectious disease epidemiology, prevention and control;
disseminate surveillance data on communicable diseases and publish analyses and interpretations of these data;
offer, where possible, assistance to authors from all European Union countries in improving the impact and quality of national information on communicable diseases.
官方網站http://www.eurosurveillance.org/
在線稿件提交https://www.editorialmanager.com/EUROSURVEILLANCE
開放訪問Yes
出版商European Centre for Disease Prevention and Control (ECDC)
主題領域INFECTIOUS DISEASES
出版國/地區SWEDEN
發行頻率週刊
創刊年1995
每年文章數192每年文章數趨勢
黃金OA百分比95.85%
OA Related Info
APC: No
APC waiver:No
Other charges: No
Keywords: communicable diseases、public health、infectious diseases、epidemiology、surveillance、prevention
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardDouble anonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
INFECTIOUS DISEASESSCIEQ16/132
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1560-7917%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Ordinary, 3-8 Week(s)
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Eurosurveillance】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE645756
    BIOMATERIALS601434
    Frontiers in Pharmacology504189
    BIOMEDICINE & PHARMACOTHERAPY498673
    JOURNAL OF ETHNOPHARMACOLOGY497105
    Journal of Materials Chemistry B476188
    Frontiers in Immunology461458
    COMPUTERS IN BIOLOGY AND MEDICINE420875
    COLLOIDS AND SURFACES B-BIOINTERFACES419562
    Frontiers in Oncology415919
  •  

    Eurosurveillance Eurosurveillance
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Eurosurveillance] 的評論撰寫評論
作者: 低拷贝


領域: 生物学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2023-07-16 15:23:12 評論於
This magazine has a high rejection rate. I have had two articles accepted, and the review process is neither fast nor slow. However, the time it takes to receive the acceptance online is very slow, with the longest wait being 8 months. The journal is free, and the editors are very helpful, willing to assist in correcting grammar errors word by word. There is no need to worry about being rejected due to language issues.
(0) 讚! | 低拷贝

作者: 虚徒丰雅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-06-08 17:25:07 評論於
How long has your approval taken?
(0) 讚! | 虚徒丰雅

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-16 16:12:42 評論於
What a windfall! Published one article last year, and now surpassed 6 points this year. Hey guys, you also need to have such vision
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-11-06 21:29:45 評論於
Review Speed: 6.0 | Submission Acceptance Rate: 25.0
Experience Sharing: The review process is relatively slow, very strict, and has high English language requirements for articles
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-10-24 13:11:26 評論於
Very professional magazine, the editorial team is dedicated, professional, responsible, and very serious
(0) 讚! | 凌霄高洁

作者: 匿名


領域:
審稿時間: 0.0 month(s)
結果:


撰寫評論

2013-05-06 20:18:00 評論於
This journal is based in SWEDEN?

(0) 讚! | 匿名

作者: 匿名


領域:
審稿時間: 0.0 month(s)
結果:


撰寫評論

2011-08-21 22:36:00 評論於
Journal Homepage URL: http://www.eurosurveillance.org/
(0) 讚! | 匿名

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Eurosurveillance] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*